Literature DB >> 12565898

Redox properties of the couples compound I/compound II and compound II/native enzyme of human myeloperoxidase.

Paul Georg Furtmüller1, Jürgen Arnhold, Walter Jantschko, Hans Pichler, Christian Obinger.   

Abstract

Myeloperoxidase (MPO) is an important component of the neutrophil's antimicrobial armory and has been implicated in promoting tissue damage in numerous inflammatory diseases. For the first time the standard reduction potential of the redox couple compound II/native enzyme has been determined to be (0.97+/-0.01)V at pH 7.0 and 25 degrees C. This was achieved by rapid mixing of preformed compound II with either tyrosine or nitrite by using the sequential-mixing stopped-flow technique and measuring spectrophotometrically the concentrations of the reacting species and products at equilibrium. Using the recently determined standard reduction potential for the couple compound I/native enzyme (1.16 V), the reduction potential of the couple compound I/compound II was calculated to be 1.35 V at pH 7 and 25 degrees C. These data reveal substantial differences between the two known heme peroxidase superfamilies and reflect the dramatic differences observed in the oxidisability of substrates by the MPO redox intermediates compound I and compound II.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12565898     DOI: 10.1016/s0006-291x(02)03075-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Redox properties of the Fe3+/Fe2+ couple in Arthromyces ramosus class II peroxidase and its cyanide adduct.

Authors:  Gianantonio Battistuzzi; Marzia Bellei; Francesca De Rienzo; Marco Sola
Journal:  J Biol Inorg Chem       Date:  2006-05-30       Impact factor: 3.358

2.  2-thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation.

Authors:  Anna-Karin Tidén; Tove Sjögren; Mats Svensson; Alexandra Bernlind; Revathy Senthilmohan; Francoise Auchère; Henrietta Norman; Per-Olof Markgren; Susanne Gustavsson; Staffan Schmidt; Stefan Lundquist; Louisa V Forbes; Nicholas J Magon; Louise N Paton; Guy N L Jameson; Håkan Eriksson; Anthony J Kettle
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

3.  Inhibition of Myeloperoxidase.

Authors:  Jala Soubhye; Paul G Furtmüller; Francois Dufrasne; Christian Obinger
Journal:  Handb Exp Pharmacol       Date:  2021

Review 4.  Myeloperoxidase in human neutrophil host defence.

Authors:  William M Nauseef
Journal:  Cell Microbiol       Date:  2014-06-19       Impact factor: 3.715

Review 5.  What really happens in the neutrophil phagosome?

Authors:  James K Hurst
Journal:  Free Radic Biol Med       Date:  2012-05-15       Impact factor: 7.376

6.  Activatable magnetic resonance imaging agents for myeloperoxidase sensing: mechanism of activation, stability, and toxicity.

Authors:  Elisenda Rodríguez; Mark Nilges; Ralph Weissleder; John W Chen
Journal:  J Am Chem Soc       Date:  2010-01-13       Impact factor: 15.419

7.  Potent reversible inhibition of myeloperoxidase by aromatic hydroxamates.

Authors:  Louisa V Forbes; Tove Sjögren; Françoise Auchère; David W Jenkins; Bob Thong; David Laughton; Paul Hemsley; Garry Pairaudeau; Rufus Turner; Håkan Eriksson; John F Unitt; Anthony J Kettle
Journal:  J Biol Chem       Date:  2013-11-05       Impact factor: 5.157

8.  Sulfite-mediated oxidation of myeloperoxidase to a free radical: immuno-spin trapping detection in human neutrophils.

Authors:  Kalina Ranguelova; Annette B Rice; Olivier M Lardinois; Mathilde Triquigneaux; Natacha Steinckwich; Leesa J Deterding; Stavros Garantziotis; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2013-01-29       Impact factor: 7.376

Review 9.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

10.  Inhibition of myeloperoxidase-mediated hypochlorous acid production by nitroxides.

Authors:  Martin D Rees; Steven E Bottle; Kathryn E Fairfull-Smith; Ernst Malle; John M Whitelock; Michael J Davies
Journal:  Biochem J       Date:  2009-06-12       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.